Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-120-7 | CAS number: 28645-51-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene Toxicity In-Vitro:
Ames Assay:
Gene toxicity in vitro study was performed to evaluate the mutagenic potential of test chemical. The test was performed using Salmonella typhimurium TA1535, TA1537, TA98, TA100, and TA102 both with and without metabolic activation system using the test material at a dose level of 33, 100, 1000, 2500, or 5000 µg/plate using ethanol as solvents. Plate incorporation protocol was followed. Test substance was considered to be non mutagenic to S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102 with and without metabolic activation in the Plate incorporation assay. Hence the test substance cannot be classified as mutagenic in vitro.
In-Vitro chromosomal aberration assay:
A chromosome aberration assay using peripheral human lymphocytes with and without metabolic activation (S9) was negative. The positive controls elicited the expected results. No clastogenic findings were observed for the test article. Thus, based on all the above observations and results , it was concluded that the test chemical did not induce any mutagenicity at any tested concentration in human lymphocytes. In another study, the test chemical was tested in vitro with human lymphocytes. The concentrations ranged from 17.81 to 2280 lg/ ml with the S9 cultures and 4.45 to 71.25 lg/ml without the S9 cultures. Since, the test chemical did not induce significant increases in the frequency of cells with chromosome aberrations or polyploidy cells in either the presence or absence of a liver enzyme metabolizing system, it was concluded that it is not clastogenic to human lymphocytes in vitro.
In vitro Mammalian cell gene mutation assay:
An in vitro mutagenicity test was performed on L5178Y mouse lymphoma cells to assess the mutagenicity of the test chemical. The assay was performed on duplicate sets both in the presence and absence of exogenous metabolic activation system. In the first set, cells were exposed to concentrations ranged from 2.5 to 40 mg/ml in the absence of metabolic activation (-S9 mix) and 5–80 mg/ml in the presence of metabolic activation (+S9). In the second experiment, concentrations employed ranged from 5-50 mg/ml (-S9) and 10-70 mg/ml (+S9). Positive and concurrent vehicle controls were also included in the assay. As seen by the results, the test substance did not induce mutation in L5178Y mouse lymphoma cell at any concentration tested, neither in the presence nor in the absence of metabolic activation and, consequently it was considered non-mutagenic (negative) in mouse lymphoma cell line, under the described experimental conditions.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: Refer below principle
- Principles of method if other than guideline:
- Bacterial gene mutation test was performed to evaluate the mutagenic potential of test substance using both plate incorporation and preincubation protocols.
- GLP compliance:
- no
- Type of assay:
- bacterial gene mutation assay
- Target gene:
- Histidine
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- No data
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9
- Test concentrations with justification for top dose:
- 33, 100, 1000, 2500, or 5000 µg/plate
- Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Plate incorporation and preincubation protocols
DURATION
- Preincubation period: No data available
- Exposure duration: No data available
- Expression time (cells in growth medium): No data available
- Selection time (if incubation with a selection agent): No data available
- Fixation time (start of exposure up to fixation or harvest of cells): No data available
SELECTION AGENT (mutation assays): No data available
SPINDLE INHIBITOR (cytogenetic assays): No data available
STAIN (for cytogenetic assays): No data available
NUMBER OF REPLICATIONS: No data available
NUMBER OF CELLS EVALUATED: No data available
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: No data available
OTHER EXAMINATIONS:
- Determination of polyploidy: No data available
- Determination of endoreplication: No data available - Rationale for test conditions:
- No data
- Evaluation criteria:
- Increase in revertants/plate was observed
- Statistics:
- No data available
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- No data available
- Remarks on result:
- other: No mutagenic potential
- Conclusions:
- Test substance did not produce reverse mutation up to 5000 µg/plate in Salmonella typhimurium tester strains of TA 1535, TA 1537, TA 98, TA 100 and TA 102 both with and without metabolic activation.
- Executive summary:
Bacterial reverse mutation assaywas performed to evaluate the mutagenic potential of test chemicalin Salmonella typhimurium tester strains of TA 1535, TA 1537, TA 98, TA 100 and TA 102. The assay was performed employing both plate incorporation and preincubation protocols.The test chemical was dissolved in ethanol and tested in concentrations of 33, 100, 1000, 2500, or 5000 µg/plate with and without rat liver microsomal activation (S9 mix). No substantial increase in number of mutant colonies compared to vehicle control was observed up to the concentration of 5000µg/plate. Hence,the test chemicalwas regarded non-mutagenic (negative) in bacterial reverse mutation assay under the experimental conditions described.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Weight of evidence approach based on the available data of the read-across chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Principles of method if other than guideline:
- Equivalent or similar to OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- not specified
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- No Data Available
- Species / strain / cell type:
- lymphocytes:
- Remarks:
- Study 2 and 3: Human Lymphocytes
- Cytokinesis block (if used):
- Study 3: Mitosis was arrested by the addition of demecolcine (Colcemid, 0.1 ug/ml) 2 h before the harvest time.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Study 2: A chromosome aberration assay using peripheral human lymphocytes with and without metabolic activation (S9) was negative.
Study 3: The concentrations ranged from 17.81 to 2280 ug/ ml with the S9 cultures and 4.45 to 71.25 ug/ml without the S9 cultures. - Test concentrations with justification for top dose:
- No Data Available
- Vehicle / solvent:
- No Data Available
- Untreated negative controls:
- other:
- Remarks:
- Study 2: yes
- Negative solvent / vehicle controls:
- other:
- Remarks:
- Study 2: not specified
- True negative controls:
- other:
- Remarks:
- Study 2: not specified
- Positive controls:
- other:
- Remarks:
- Study 2: yes;
- Positive control substance:
- other: Please see 'remarks'
- Remarks:
- Study 3: Positive controls were ethyl methanesulfonate (500 ug/ml) in dimethylsulfoxide when S9 was absent and cyclophosphamide (25 ug/ml) dissolved in the culture medium without serum for cultures where S9 was included.
- Details on test system and experimental conditions:
- Study 2: A chromosome aberration assay using peripheral human lymphocytes with and without metabolic activation (S9) was negative.
Study 3: The concentrations ranged from 17.81 to 2280 ug/ ml with the S9 cultures and 4.45 to 71.25 ug/ml without the S9 cultures. Chromosome damage was assessed by counting the first 100 consecutive ‘‘well-spread’’ metaphases from each culture. Gaps, breaks, or rearrangements were noted. Cells with more than 44 chromosomes were also noted. The mitotic index was based on a count of 2000 lymphocytes, noting those in metaphase. - Rationale for test conditions:
- No Data Available
- Evaluation criteria:
- No Data Available
- Statistics:
- No Data Available
- Species / strain:
- lymphocytes:
- Remarks:
- Study 2 and 3: Human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- The chemicals in Study 2 and Study 3 were found to be non-genotoxic.
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Remarks:
- Study 3: The vehicle control gave frequencies within historical control values.
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks:
- Study 3: Both positive controls gave statistically significant increases in the frequency of cells with aberrations.
- Additional information on results:
- Study 2: In experiment 1, doses of 18.59, 37.19, 74.38, 148.75, 297.5, 595, 1190, or 2380 ug/ml (±S9) were exposed up to 20 h. In experiment 2, the cells were dosed up to 600 ug/ml (+S9) and 150 ug/ml (S9) then exposed for 20 h or dosed up to 300 ug/ml (+S9) and 150 ug/ ml (S9) then exposed for 44 h. The positive controls elicited the expected results. No clastogenic findings were observed for the test article.
Study 3: The test chemical was not found to be mutagenic at any given dose concentration, - Remarks on result:
- other: Study 2 and 3: No mutagenic potential of the test chemical was observed.
- Conclusions:
- Based on all the above observations and results, it has been concluded that the test chemical is not clastogenic as it has not induced chromosome aberration at any dose tested in human lymphocytes neither in presence nor in the absence of metabolic activation system.
- Executive summary:
In vitro chromosomal aberration studies:
The clastogenic nature of the test chemical was assessed by in vitro mammalian chromosomal aberration test using cultured human lymphocytes, as test system.
Study 1:
The clastogenic activity of the test compound was assessed in a chromosome aberration assay using peripheral human lymphocytes. Duplicate cultures were treated with the test chemical at graded concentrations and two exposure periods (20 and 44 hours). In experiment 1, cells were exposed to doses of 18.59, 37.19, 74.38, 148.75, 297.5, 595, 1190, or 2380 mg/ml up to 20 hours both in the presence and in the absence of metabolic activation system (S9 mix). In experiment 2, the cells were dosed with 37.5, 75, 150, 225, 300, 600 (+S9 mix) or with 18.75, 37.5, 75, 112.5, 150 (-S9 mix) then exposed for 20 hours. Alternatively, cells were exposed to doses of 150, 225, 300 (+S9 mix) or 37.5, 75, 112.5, 150 (-S9 mix) then exposed for 44 hours. The positive controls elicited the expected results. No clastogenic findings were observed for the test compound at any doses applied, neither in the presence nor in the absence of metabolic activation, in both experiments. Hence, the test chemical was considered non-clastogenic (negative) in a chromosome aberration test, in peripheral human lymphocytes under the described experimental conditions.
Study2:
A chromosome aberration assay was conducted using human lymphocytes to assess the clastogenic nature of the test substance. The test chemical was employed in concentrations ranged from 17.81 to 2280 ug/ml with metabolic activation (+S9) and from 4.45 to 71.25 ug/ml without metabolic activation (-S9) for 20 hours. Positive and concurrent solvent control were also included in the text. Chromosome damage was assessed by counting the first 100 consecutive ‘‘well-spread’’ metaphases from each culture. Gaps, breaks, or rearrangements were noted. Cells with more than 44 chromosomes were also noted. Both positive controls gave statistically significant increases in the frequency of cells with aberrations, the vehicle control gave frequencies within historical control values. The test chemical did not induce significant increase the frequency of cells with chromosome aberrations or polyploidy cells neither in the presence or nor in the absence of a liver enzyme metabolizing system. Hence, it was concluded that the test chemical is not clastogenic to human lymphocytes in vitro, under the described experimental conditions.
Based on all the above observations and results, ithas beenconcluded that the test chemicalis notclastogenic as it has not induced structural or numerical chromosome aberrationat anydose testedin human lymphocytes neither in presence nor in the absence of metabolic activation system.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data from handbook or collection of data
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: Refer below principle
- Principles of method if other than guideline:
- Weight of evidence prepared from various studies mention below
Study 5: The gene mutation study was conducted according to L5178Y TK+/- Mouse Lymphoma Mutagenicity Assay to determine the mutagenic nature of the test chemical
Study 6: To evaluate the mutagenic potential of test substance in Chinese hamster ovary (CHO) K1 cells by HGPRT Assay. - GLP compliance:
- not specified
- Type of assay:
- other: Study 5: in vitro mammalian cell gene mutation tests using the thymidine kinase gene. Study 6: HGPRT Assay
- Target gene:
- Study 5: Thymidine kinase
Study 6: HGPRT - Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- L5178Y TK ±3.7.2c mouse lymphoma cells were used in this study.
- Additional strain / cell type characteristics:
- not specified
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Remarks:
- ) K1 cells
- Details on mammalian cell type (if applicable):
- Not specified
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- No Data Available
- Metabolic activation:
- with and without
- Metabolic activation system:
- Study 5: In the first set, concentrations ranged from 2.5 to 40 ug/ml in the absence of metabolic activation (S9) and 5–80 ug/ml in the presence of metabolic activation (+S9). In the second set, concentrations ranged from 5–50 ug/ml without S9 metabolic system and 10–70 ug/ml with S9 metabolic system.
- Test concentrations with justification for top dose:
- Study 5: 1st set: In absence of metabolic activation system: 40 ug/ml and in presence of metabolic activation system: 80 ug/ml.
2nd set: In absence of metabolic activation system: 50 ug/ml and in presence of metabolic activation system: 70 ug/ml.
Study 6: 8 – 80 µg/mL - Vehicle / solvent:
- No Data Available
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- not specified
- True negative controls:
- not specified
- Positive controls:
- yes
- Details on test system and experimental conditions:
- Study 5: In the first set, concentrations ranged from 2.5 to 40 ug/ml in the absence of metabolic activation (S9) and 5–80 ug/ml in the presence of metabolic activation (+S9). In the second set, concentrations ranged from 5–50 ug/ml without S9 metabolic system and 10–70 ug/ml with S9 metabolic system.
- Rationale for test conditions:
- No data
- Evaluation criteria:
- Study 6: Mammalian cells were evaluated for mutagenic potential.
- Statistics:
- No data available
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- There were no effects with the test chemical.
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks:
- Positive controls elicited the expected results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Remarks:
- K1 cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Additional information on results:
- No data
- Remarks on result:
- other: No mutagenicity potential of the test chemical was determined at the all the concentration tested.
- Conclusions:
- Based on all the above observations and results, it has been concluded that the test chemical is not mutagenic at doses tested both in the presence and in the absence of metabolic activation.
- Executive summary:
In vitro mammalian cell gene mutation assays:
Study 7:
An in vitro mutagenicity test was performed on L5178Y mouse lymphoma cells to assess the mutagenicity of the test chemical. The assay was performed on duplicate sets both in the presence and absence of exogenous metabolic activation system. In the first set, cells were exposed to concentrations ranged from 2.5 to 40 mg/ml in the absence of metabolic activation (-S9 mix) and 5–80 mg/ml in the presence of metabolic activation (+S9). In the second experiment, concentrations employed ranged from 5-50 mg/ml (-S9) and 10-70 mg/ml (+S9). Positive and concurrent vehicle controls were also included in the assay. As seen by the results, the test substance did not induce mutation in L5178Y mouse lymphoma cell at any concentration tested, neither in the presence nor in the absence of metabolic activation and, consequently it was considered non-mutagenic (negative) in mouse lymphoma cell line, under the described experimental conditions.
Study 8:
An in vitro mammalian cell gene mutagenicity test using the Hprt gene was performed using Chinese hamster ovary K1 cells to investigate the mutagenic potential of the test chemical. The cells were exposed to the test chemical at concentrations of 0 (vehicle control), 20, 40, 60, 80 µg/ml for 4 hours. The test was conducted on duplicates both in the presence and absence of exogenous metabolic activation (S9 mix). Positive and concurrent negative controls were also included in the assay. Statistically significant and dose-related increase in mutant frequency over the control was considered as positive result. No cytotoxicity was observed up to 80 µg/ml. In addition, the test substance did not increase the mutant frequency at any doses tested, neither in the presence nor in the absence of metabolic activation. Hence, the test chemical was not mutagenic at Hprt locus in CHO cells both with and without metabolic activation, in a mammalian gene mutation test.
Based on all the above observations and results, ithas beenconcluded that the test chemicalhas notinducedgene mutationat any tested concentrationneither in thepresencenor in theabsence of S9 metabolic activation system.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Data fonthe test chemicalsand read across analogueswerereviewed to determine thegenotoxicnature of the test chemical. The studies are as mentioned below:
AMES test:
#1
Bacterial reverse mutation assay was performed to evaluate the mutagenic potential of test chemical in Salmonella typhimurium tester strains of TA 1535, TA 1537, TA 98, TA 100 and TA 102. The assay was performed employing both plate incorporation and preincubation protocols. The test chemical was dissolved in ethanol and tested in concentrations of 33, 100, 1000, 2500, or 5000 µg/plate with and without rat liver microsomal activation (S9 mix). No substantial increase in number of mutant colonies compared to vehicle control was observed up to the concentration of 5000µg/plate. Hence, the test chemical was regarded non-mutagenic (negative) in bacterial reverse mutation assay under the experimental conditions described.
In vitro chromosomal aberration study:
#1
The clastogenic activity of the test compound was assessed in a chromosome aberration assay using peripheral human lymphocytes. Duplicate cultures were treated with the test chemical at graded concentrations and two exposure periods (20 and 44 hours). In experiment 1, cells were exposed to doses of 18.59, 37.19, 74.38, 148.75, 297.5, 595, 1190, or 2380 mg/ml up to 20 hours both in the presence and in the absence of metabolic activation system (S9 mix). In experiment 2, the cells were dosed with 37.5, 75, 150, 225, 300, 600 (+S9 mix) or with 18.75, 37.5, 75, 112.5, 150 (-S9 mix) then exposed for 20 hours. Alternatively, cells were exposed to doses of 150, 225, 300 (+S9 mix) or 37.5, 75, 112.5, 150 (-S9 mix) then exposed for 44 hours. The positive controls elicited the expected results. No clastogenic findings were observed for the test compound at any doses applied, neither in the presence nor in the absence of metabolic activation, in both experiments. Hence, the test chemical was considered non-clastogenic (negative) in a chromosome aberration test, in peripheral human lymphocytes under the described experimental conditions.
#2
A chromosome aberration assay was conducted using human lymphocytes to assess the clastogenic nature of the test substance. The test chemical was employed in concentrations ranged from 17.81 to 2280 ug/ml with metabolic activation (+S9) and from 4.45 to 71.25 ug/ml without metabolic activation (-S9) for 20 hours. Positive and concurrent solvent control were also included in the text. Chromosome damage was assessed by counting the first 100 consecutive ‘‘well-spread’’ metaphases from each culture. Gaps, breaks, or rearrangements were noted. Cells with more than 44 chromosomes were also noted. Both positive controls gave statistically significant increases in the frequency of cells with aberrations, the vehicle control gave frequencies within historical control values. The test chemical did not induce significant increase the frequency of cells with chromosome aberrations or polyploidy cells neither in the presence or nor in the absence of a liver enzyme metabolizing system. Hence, it was concluded that the test chemical is not clastogenic to human lymphocytes in vitro, under the described experimental conditions.
In vitro mammalian cell gene mutation assay:
#1
An in vitro mutagenicity test was performed on L5178Y mouse lymphoma cells to assess the mutagenicity of the test chemical. The assay was performed on duplicate sets both in the presence and absence of exogenous metabolic activation system. In the first set, cells were exposed to concentrations ranged from 2.5 to 40 mg/ml in the absence of metabolic activation (-S9 mix) and 5–80 mg/ml in the presence of metabolic activation (+S9). In the second experiment, concentrations employed ranged from 5-50 mg/ml (-S9) and 10-70 mg/ml (+S9). Positive and concurrent vehicle controls were also included in the assay. As seen by the results, the test substance did not induce mutation in L5178Y mouse lymphoma cell at any concentration tested, neither in the presence nor in the absence of metabolic activation and, consequently it was considered non-mutagenic (negative) in mouse lymphoma cell line, under the described experimental conditions.
#2
An in vitro mammalian cell gene mutagenicity test using the Hprt gene was performed using Chinese hamster ovary K1 cells to investigate the mutagenic potential of the test chemical. The cells were exposed to the test chemical at concentrations of 0 (vehicle control), 20, 40, 60, 80 µg/ml for 4 hours. The test was conducted on duplicates both in the presence and absence of exogenous metabolic activation (S9 mix). Positive and concurrent negative controls were also included in the assay. Statistically significant and dose-related increase in mutant frequency over the control was considered as positive result. No cytotoxicity was observed up to 80 µg/ml. In addition, the test substance did not increase the mutant frequency at any doses tested, neither in the presence nor in the absence of metabolic activation. Hence, the test chemical was not mutagenic at Hprt locus in CHO cells both with and without metabolic activation, in a mammalian gene mutation test.
Justification for classification or non-classification
The mutagenic potential ofthe target chemicalhas been thoughtfully investigated by a combination of in vitro tests: bacterial reverse mutation assay, chromosome aberration and gene mutation tests of cultured mammalian cell lines. The combination of these test approaches covers gene and chromosome mutations and clastogenic activity in somatic cells.Conclusive evidence from the studies discuss below have indicated, thatthe target chemicaldid not induce alterations in genetic material such as gene and chromosome mutations, structural and numerical chromosome aberrations in somatic cells, in vitro and, consequentlyithas beennotclassifiedfor mutagenicityaccording to the criteria of the CLP regulations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.